1444001-05-1

Basic information

• Product Name: (S)-ethyl 1-(4-(5-((2-((tert-butoxycarbonyl)amino)thiazole-5-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)piperidine-4-carboxylate
• Synonyms: (S)-ethyl 1-(4-(5-((2-((tert-butoxycarbonyl)amino)thiazole-5-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)piperidine-4-carboxylate
• CAS NO: 1444001-05-1
• Molecular Weight: 573.67
• Mol File: 1444001-05-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (S)-ethyl 1-(4-(5-((2-((tert-butoxycarbonyl)amino)thiazole-5-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)piperidine-4-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-ethyl 1-(4-(5-((2-((tert-butoxycarbonyl)amino)thiazole-5-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)piperidine-4-carboxylate(1444001-05-1)
• EPA Substance Registry System: (S)-ethyl 1-(4-(5-((2-((tert-butoxycarbonyl)amino)thiazole-5-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)piperidine-4-carboxylate(1444001-05-1)

Safety Data

• Hazardous Substances Data: 1444001-05-1(Hazardous Substances Data)

Upstream product

• 1126-09-6 4-carbethoxypiperidine 
• 350-46-9 4-Fluoronitrobenzene 
• 1444001-04-0 (S)-ethyl 1-(4-(5-(aminomethyl)-2-oxooxazolidin-3-yl)phenyl)piperidine-4-carboxylate 
• 302964-20-1 2-tert-butoxycarbonylamino-1,3-thiazole-5-carboxylic acid chloride 
• 216985-30-7 ethyl 1-(4-Nitrophenyl)-4-piperidine carboxylate 
• 439095-52-0 ethyl 1-(4-aminophenyl)piperidine-4-carboxylate 
• 1444001-02-8 (S)-ethyl 1-(4-((3-(1,3-dioxoisoindolin-2-yl)-2-hydroxypropyl)amino)phenyl)piperidine-4-carboxylate 
• 1444001-03-9 (S)-ethyl 1-(4-(5-((1,3-dioxoisoindolin-2-yl)methyl)-2-oxooxazolidin-3-yl)phenyl)piperidine-4-carboxylate 

Relevant articles and documents

Low molecular weight dual inhibitors of factor Xa and fibrinogen binding to GPIIb/IIIa with highly overlapped pharmacophores

Dual antithrombotic agents acting as anticoagulants and aggregation inhibitors could have substantial advantages over currently prescribed combinations of antithrombotic drugs. Herein, we report compounds with moderate inhibitory activity for factor Xa an